Windamere Venture Partners, an early-stage investment firm, finances pharmaceutical, biotechnology, and other healthcare companies.
Since its inception in 1998, Windamere Venture Partners has supported more than a dozen pharmaceutical, biotechnology, medical device, and other healthcare companies from the very early stages. Their unique approach combines a specialized investment focus with active management and long-term commitment to ensure the highest rates-of-return for both entrepreneurs and investors.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Feb 26, 2008
Cianna Medical
|
Series A | $9M | Health Care | — |
Jun 3, 2002
Dexcom
|
Series C | $30M | Biotechnology | — |